Sudarshan Pharma Reports 44.8% Profit Rise; Stock Gains Amid CFO Resignation
2 hours agoBusiness
32LENS
2 Sources
TBNthebalanced.news

Sudarshan Pharma Reports 44.8% Profit Rise; Stock Gains Amid CFO Resignation

Sudarshan Pharma Industries reported a 44.8% rise in net profit to Rs 10.73 crore and a 36.7% increase in quarterly revenue to Rs 220.92 crore for March 2026, with annual net profit and sales also showing significant growth. The stock gained about 4% following these results amid broader market gains. The company announced CFO Sachin Mehta's resignation effective May 1, 2026, while he continues as Joint Managing Director, ensuring leadership continuity during the transition.

Political Bias
0%100%0%
Sentiment
72%
AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 4 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 2 sources
● Left 0%● Center 100%● Right 0%

The articles focus primarily on financial performance and corporate leadership changes without political framing. Coverage centers on business metrics and company announcements, reflecting a neutral, market-oriented perspective. There is no evident political bias, as the sources emphasize operational and stock market developments rather than political implications.

Sentiment — Positive (72/100)

The overall tone is positive, highlighting strong profit and revenue growth alongside a stock price increase. The mention of the CFO resignation is presented factually, with emphasis on leadership continuity, maintaining a balanced and professional sentiment. There is no negative or sensational language, resulting in an optimistic yet measured coverage.

How 2 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
indiatvnewsPharma stock below Rs 50 in focus after quarterly profit increases, check share priceCenterPositive
mintSmall-cap pharma stock under 50 jumps 4 following Dalal Street rally Stock Market NewsCenterPositive

Coverage timeline

mint broke this story on 4 May, 05:30 am. Other outlets followed.

  1. 1
    mint4 May, 05:30 am
    Small-cap pharma stock under 50 jumps 4 following Dalal Street rally Stock Market News
  2. 2
    indiatvnews4 May, 07:15 am
    Pharma stock below Rs 50 in focus after quarterly profit increases, check share price

Lens Score breakdown

32/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Sudarshan PharmaSudarshan Pharma IndustriesNSEBSE

Story context

Category
Business
Sources analysed
2
Last analysed
4 May 2026
Key entities
CroreIndian rupeeNet incomeFiscal yearBSE SENSEXPrice of oilChemical substanceBombay Stock ExchangeAsiaNational Stock Exchange of IndiaRelative strength indexDelhi Metro